Alpha Teknova (NASDAQ:TKNO) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Alpha Teknova (NASDAQ:TKNO) announced its quarterly earnings results on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01, Zacks reports. Alpha Teknova had a negative net margin of 55.24% and a negative return on equity of 26.51%. The firm had revenue of $10.45 million for the quarter, compared to the consensus estimate of $10.23 million. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Stock Performance

Alpha Teknova stock opened at $4.81 on Friday. The firm’s fifty day moving average price is $5.09 and its 200-day moving average price is $5.29. The company has a debt-to-equity ratio of 0.17, a quick ratio of 4.70 and a current ratio of 5.87. The stock has a market cap of $257.38 million, a P/E ratio of -11.45 and a beta of 0.39. Alpha Teknova has a fifty-two week low of $3.94 and a fifty-two week high of $10.37.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in TKNO. Balyasny Asset Management L.P. raised its position in Alpha Teknova by 19.5% during the second quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company’s stock valued at $4,912,000 after purchasing an additional 163,526 shares in the last quarter. Massar Capital Management LP increased its position in shares of Alpha Teknova by 185.7% during the 2nd quarter. Massar Capital Management LP now owns 200,000 shares of the company’s stock valued at $982,000 after purchasing an additional 130,000 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Alpha Teknova by 64.4% during the 2nd quarter. Geode Capital Management LLC now owns 298,850 shares of the company’s stock valued at $1,468,000 after buying an additional 117,016 shares in the last quarter. Marshall Wace LLP lifted its position in Alpha Teknova by 83.0% in the 2nd quarter. Marshall Wace LLP now owns 90,032 shares of the company’s stock worth $442,000 after buying an additional 40,825 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in Alpha Teknova by 68.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 90,595 shares of the company’s stock worth $470,000 after buying an additional 36,763 shares during the last quarter. Institutional investors own 13.81% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on TKNO. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alpha Teknova in a report on Wednesday, October 8th. Stephens upgraded shares of Alpha Teknova to a “strong-buy” rating and set a $8.00 price target for the company in a research report on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $10.00.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.